Everolimus Tablet
Product Images NDC 63850-0063
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Everolimus (NDC 63850-0063). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Natco Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Everolimus-fig-1 (Everolimus Fig 1)
0-25mg-bottle-label (Everolimus 0 25mg Bottle Label)
0-5mg-bottle-label (Everolimus 0 5mg Bottle Label)
0-75mg-bottle-label (Everolimus 0 75mg Bottle Label)
Bottle-label (Everolimus 1mg Bottle Label)
Foil (Everolimus 0 5mg Foil)
Carton (Everolimus 0 5mg Carton)
Foil (Everolimus 0 75mg Foil)
Carton (Everolimus 0 75mg Carton)
Blister-foil (Everolimus 1mg Blister Foil Label)
Bottle-carton (Everolimus 1mg Blister Carton Label)
Foil (Everolimus 0 25mg Foil)
Carton (Everolimus 0 25mg Carton)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.